The Food and Drug Administration is reinstating telework for staff who review drugs, medical devices, and tobacco, according ...

Dr. Peter Marks, an ex-FDA vaccine official, is warning of a fundamental change at the agency—where vaccine skepticism now ...

Far as he was from Washington, D.C., as Health and Human Services Secretary Robert F. Kennedy Jr. hiked to the top of a ...

Weeks after ordering all Food and Drug Administration employees back into the office, the agency is reversing course, ...

As the biopharma industry grapples with the uncertain macro environment brought on by the new administration, CEOs, ...

Health Secretary Robert F. Kennedy Jr. spent a portion of his speech on Friday to FDA staff deriding their past decisions, at ...

A former top FDA official said it’s only a matter of time before the chaos at the agency starts to impact drug reviews.

Trump's health secretary told FDA workers that tackling childhood chronic diseases should be the agency's chief priority.

Right off the bat, the high-profile departure of Peter Marks, M.D., Ph.D., former director of the FDA’s Center for Biologics ...

Shuren, who retired from his spot leading the FDA’s Center for Devices and Radiological Health (CDRH) in 2024, said last week ...

Amid a massive reorganization of the federal healthcare infrastructure that has prompted pushback from biotech and healthcare ...